Table 2.

Relationship between SNHG12 expression and clinicopathological characteristics

Characteristics	Patients frequency (%)	SNHG12		P value
		Low	High
Total	102	51	51
Age
< 60	52 (51.0)	27	25	0.692
> 60	50 (49.0)	24	26
Tumor size				0.012*,a
< 2 cm	29 (28.4)	20	9
2-5 cm	69 (67.6)	30	39
> 5 cm	4 (3.9)	1	3
Lymph node metastasis				0.041*
No	38 (37.3)	24	14
Yes	64 (62.7)	27	37
Distant metastasis				1.000
No	93 (91.2)	46	47
Yes	9 (8.8)	5	4
Stage				0.053
I-II	71 (69.6)	40	31
III-IV	31 (30.4)	11	20
Tumor grade				0.739a
I	8 (7.8)	3	5
II	62 (60.8)	33	29
III	32 (31.4)	15	17

^aWilcoxon test;

^*P < 0.05.